Magnify

The Next Generation Incubator

InSpira is focused on the development of breakthrough treatments and, ultimately, a cure for pulmonary fibrosis and other fibrotic diseases.

Inspira, LLC is developing breakthrough treatments and, ultimately, a cure for pulmonary fibrosis and other fibrotic diseases. Idiopathic Pulmonary Fibrosis (IPF) is a chronic and ultimately fatal disease characterized by a progressive decline in lung function. With over 73,000 new cases each year, patients on average live just 3-5 years after diagnosis. Inspira is developing novel compounds shown to inhibit and even reverse pulmonary fibrosis. Used along with their induced pluripotent stem cell model and other assays, Inspira is making breakthrough improvements in IPF research.

Graduated in 2018
Location: Los Angeles, CA

Contact:
Email: info@inspiracures.com
Phone: 949-355-5158
Website: www.inspiracures.com